Keymed Biosciences Inc. Share Price
Stocks
2162
KYG5252B1023
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
08:08:17 13/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 69.85 HKD | -1.62% |
|
+0.79% | +30.68% |
| Market Cap | 17.51B 20.58B 2.62B 2.38B 2.2B 1.98B 3.74B 247B 3.87B 26.41B 10.47B 132B 9.84B 9.63B 419B | P/E 2026 * |
22.1x | P/E 2027 * | 404x |
|---|---|---|---|---|---|
| Enterprise Value | 16.61B 19.52B 2.49B 2.26B 2.09B 1.88B 3.55B 235B 3.67B 25.06B 9.94B 125B 9.34B 9.14B 398B | EV / Sales 2026 * |
10.2x | EV / Sales 2027 * | 7.46x |
| Free-Float |
74.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2162 | Delayed | |
Tradegate
| 64Z | Real-time | |
|
Deutsche Boerse AG
| 64Z | Delayed |
| 1 day | -1.62% | ||
| 1 week | +0.79% | ||
| Current month | +4.18% | ||
| 1 month | -9.46% | ||
| 3 months | -10.62% | ||
| 6 months | +2.05% | ||
| Current year | +30.68% |
| 1 week | 68.5 |  | 75.65 |
| 1 month | 62.45 | | 89.45 |
| Current year | 44.66 | | 89.75 |
| 1 year | 44.66 | | 89.75 |
| 3 years | 26.6 | | 89.75 |
| 5 years | 16.9 | | 89.75 |
| 10 years | 16.9 | | 89.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 52 | 22/04/2018 |
Changyu Wang
PRN | Corporate Officer/Principal | 61 | 02/03/2021 |
Pak Yu Tam
SEC | Corporate Secretary | - | 28/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Chen
CHM | Chairman | 52 | 22/04/2018 |
Changyu Wang
BRD | Director/Board Member | 61 | 02/03/2021 |
Gang Xu
BRD | Director/Board Member | 52 | 20/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/06/25 | Moonshot Holdings Ltd.
| Other | Company | 21,600,000 | 7.7216% | |
| 11/06/25 | Moonshot Holdings Ltd.
| Other | Company | 18,800,000 | 6.7206% | |
| 15/09/23 | Moonshot Holdings Ltd.
| Other | Company | 114,500 | 0.0409% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.62% | +0.79% | +15.45% | +31.67% | 2.62B | |
| -2.69% | -0.48% | +53.97% | +70.99% | 66.33B | |
| -0.92% | +7.67% | +12.64% | +92.55% | 60.62B | |
| 0.00% | +0.39% | +22.34% | +90.83% | 55.5B | |
| +0.14% | +2.35% | +13.86% | +106.64% | 47.58B | |
| -2.21% | -2.47% | +20.18% | +32.24% | 43.69B | |
| -2.30% | -10.40% | +154.30% | +725.54% | 37.27B | |
| +2.15% | +1.42% | +14.58% | +54.23% | 36.57B | |
| -2.32% | -2.24% | +76.50% | +54.55% | 32.22B | |
| +2.62% | +5.90% | -37.29% | +393.72% | 26.58B | |
| Average | -0.72% | +0.12% | +34.65% | +165.30% | 41B | |
| Weighted average by Cap. | -0.83% | +0.20% | +36.49% | +154.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.63B 1.92B 244M 221M 205M 185M 348M 23.02B 360M 2.46B 975M 12.3B 916M 897M 39.04B | 2.25B 2.65B 337M 306M 283M 255M 481M 31.79B 498M 3.4B 1.35B 16.98B 1.27B 1.24B 53.91B |
| Net income | 680M 799M 102M 92.33M 85.4M 77.05M 145M 9.61B 150M 1.03B 407M 5.13B 382M 374M 16.29B | 16.85M 19.8M 2.52M 2.29M 2.12M 1.91M 3.6M 238M 3.72M 25.41M 10.08M 127M 9.47M 9.27M 403M |
| Net Debt | -897M -1.05B -134M -122M -113M -102M -191M -12.67B -198M -1.35B -536M -6.77B -504M -493M -21.48B | -717M -843M -107M -97.35M -90.04M -81.24M -153M -10.13B -158M -1.08B -429M -5.41B -403M -395M -17.18B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | HK$69.85 | -1.62% | 1,711,003 |
| 12/11/26 | HK$71.00 | -0.35% | 1,180,000 |
| 11/11/26 | HK$71.25 | -1.72% | 1,322,200 |
| 10/11/26 | HK$72.50 | -0.48% | 940,700 |
| 09/11/26 | HK$72.85 | +5.12% | 2,695,893 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2162 Stock
Select your edition
All financial news and data tailored to specific country editions
